Journal of the Neurological Sciences 1998: Vol 159 Index

5 Pages·1998·0.99 MB·English

JOURNOAFLT H E
NEUROLOGICAL
SCIENCES
Journal of the Neurological Sciences 159 (1998) 237-239
Author Index Volume 159
Akiyama, H., see Iseki, E. (159) 194 Evers, S., see Husstedt, I-W. (159) 54
Al Boukai, A., see Andeejani, A.M.I. (159) 11 Fidzianska, A., Toniolo, D. and Hausmanowa-Petrusewicz, I.
Al Damegh, S., see Andeejani, A.M.I. (159) 11 Ultrastructural abnormality of sarcolemmal nuclei in Emery-
Alvarez, J., see Nien, J.K. (159) 17 Dreifuss muscular dystrophy (EDMD) (159) 88
Amano, N., see Li, F. (159) 73 Filippi, M., Mastronardo, G., Bastianello, S., Rocca, M.A., Rovaris,
Andeejani, A.M.I., Salih, M.A.M., Kolawole, T., Gader, A., Malabarey, M., Gasperini, C., Pozzilli, C. and Comi, G.
T.O., Al Damegh, S. and Al Boukai, A. A longitudinal brain MRI study comparing the sensitivities of the
Moyamoya syndrome with unusual angiographic findings and conventional and a newer approach for detecting active lesions in
protein C deficiency: Review of the literature (159) 11 multiple sclerosis (159) 94
Archelos, J.J., Jung, S., Rinner, W., Lassmann, H., Miyasaka, M. and Filippi, M., Rocca, M.A. and Comi, G.
Hartung, H.-P. Magnetization transfer ratios of multiple sclerosis lesions with
Role of the leukocyte-adhesion molecule L-selectin in variable durations of enhancement (159) 162
experimental autoimmune encephalomyelitis (159) 127 Finsterer, J., Shorny, S., Capek, J., Cerny-Zacharias, C., Pelzl, B.,
Attanasio, A., see Troisi, E. (159) 115 Messner, R., Bittner, R.E. and Mamoli, B.
Axelrod, F.B., see Hilz, M.J. (159) 219 Lactate stress test in the diagnosis of mitochondrial myopathy
Bando, M., see Sakurai, Y. (159) 156 (159) 176
Barrientos, A., see Masanés, F. (159) 226 Fujihara, K. and Miyoshi, T.
Bastianello, S., see Filippi, M. (159) 94 The effects of 4-aminopyridine on motor evoked potentials in
Bennett, J.L., see Gilden, D.H. (159) 140 multiple sclerosis (159) 102
Bittner, R.E., see Finsterer, J. (159) 176 Fukazawa, T., see Sasaki, H. (159) 202
Blombach, S., see Kotterba, S. (159) 45 Fukusako, Y., see Sakurai, Y. (159) 156
Bolton, C.F., see Zifko, U.A. (159) 186 Furubayashi, T., see Ugawa, Y. (159) 25
Boon, M., see De Keyser, J. (159) 51 Gader, A., see Andeejani, A.M.I. (159) 11
Bragoni, M., see Troisi, E. (159) 115 Gasperini, C., see Filippi, M. (159) 94
Busto, R., see Kim, Y. (159) 1 Gilden, D.H., Bennett, J.L., Kleinschmidt-DeMasters, B.K., Song, D.D.,
Caltagirone, C., see Troisi, E. (159) 115 Yee, A.S. and Steiner, I.
Capek, J., see Finsterer, J. (159) 176 The value of cerebrospinal fluid antiviral antibody in the diagnosis
Cartier, L., see Nien, J.K. (159) 17 of neurologic disease produced by varicella zoster virus (159) 140
Casademont, J., see Masanés, F. (159) 226 Gilden, D.H., see Kleinschmidt-DeMasters, B.K. (159) 213
Cebrian, M., see Masanés, F. (159) 226 Ginsberg, M.D., see Kim, Y. (159) 1
Cerny-Zacharias, C., see Finsterer, J. (159) 176 Goto, Yu.-i., see Ozawa, M. (159) 170
Chaturvedi, S. and Dzieczkowski, J. Grau, J.M., see Masanés, F. (159) 226
Multiple hemostatic abnormalities in young adults with activated Grotemeyer, K.H., see Husstedt, I.W. (159) 54
protein C resistance and cerebral ischemia (159) 209 Haertl, U., see Hilz, M.J. (159) 219
Chen, C.-C., Chen, J.-T., Wu, Z.-A., Kao, K.-P. and Liao, K.-K. Hamada, T., see Sasaki, H. (159) 202
Cutaneous reflexes in patients with acute lacunar infarctions (159) Hanajima, R., see Ugawa, Y. (159) 25
28 Harder, T., see Reimers, C.D. (159) 60
Chen, J.-T., see Chen, C.-C. (159) 28 Hartung, H.-P., see Archelos, J.J. (159) 127
Comi, G., see Filippi, M. (159) 94 Hasegawa, K., see Toyoshima, I. (159) 38
Comi, G., see Filippi, M. (159) 162 Hashimoto, K., Higuchi, I., Osame, M. and Izumo, S.
De Keyser, J., Zwanikken, C. and Boon, M. Quantitative in situ PCR assay of HTLV-1 infected cells in
Effects of influenza vaccination and influenza illness on peripheral blood lymphocytes of patients with ATL, HAM/TSP
exacerbations in multiple sclerosis (159) 51 and asymptomatic carriers (159) 67
de Pedro-Cuesta, J., see Jin, Ya.-P. (159) 107 Hashimoto, T., see Hirohata, S. (159) 181
Ducrocq, X., Hassler, W., Moritake, K., Newell, D.W., Von Reutern, Hassler, W., see Ducrocq, X. (159) 145
G.-M., Shiogai, T. and Smith, R.R. Hausmanowa-Petrusewicz, I., see Fidziafiska, A. (159) 88
Consensus opinion on diagnosis of cerebral circulatory arrest using Hermann, K., see Hilz, M.J. (159) 219
Doppler-sonography. Task Force Group on cerebral death of the Higuchi, I., see Hashimoto, K. (159) 67
Neurosonology Research Group of tlie World Federation of Hilz, M.J., Axelrod, F.B., Hermann, K., Haertl, U., Duetsch, M. and
Neurology (159) 145 Neundorfer, B.
Duetsch, M., see Hilz, M.J. (159) 219 Normative values of vibratory perception in 530 children,
Duscha, C., see Kotterba, S. (159) 45 juveniles and adults aged 3-79 years (159) 219
Dzieczkowski, J., see Chaturvedi, S. (159) 209 Hino, H., see Iseki, E. (159) 194
PII: S0022-510X(97)00235-4
238 Author Index Volume 159
Hirohata, S., Suda, H. and Hashimoto, T. Marcoux, H.L., see Kleinschmidt-DeMasters, B.K. (159) 213
Low-dose weekly methotrexate for progressive neuropsychiatric Masamune, O., see Toyoshima, I. (159) 38
manifestations in Behcet’s disease (159) 181 Masanés, F., Barrientos, A., Cebrian, M., Pedrol, E., Mird, O.,
Hirota, K., see Toyoshima, I. (159) 38 Casademont, J. and Grau, J.M.
Husstedt, LW., Evers, S., Reichelt, D., Sprinz, A., Riedasch, M. and Clinical, histological and molecular reversibility of zidovudine
Grotemeyer, K.H. myopathy (159) 226
Progressive peripheral and central sensory tract lesion in HIV- Mastronardo, G., see Filippi, M. (159) 94
infected patients evidenced by evoked potentials. (A three-year Matsuura, T., see Ogata, A. (159) 135
follow-up study) (159) 54 Matteis, M., see Troisi, E. (159) 115
Hyodo, A., see Kobayashi, M. (159) 166 Messner, R., see Finsterer, J. (159) 176
Igarashi, S., see Sasaki, H. (159) 202 Mills, K.R. and Nithi, K.A.
Ikeda, K., see Iseki, E. (159) 194 Peripheral and central motor conduction in amyotrophic lateral
Ikeuchi, T., see Sasaki, H. (159) 202 sclerosis (159) 82
Inoue, K., see Sakurai, Y. (159) 156 Mir6, O., see Masanés, F. (159) 226
Iseki, E., see Li, F. (159) 73 Miyasaka, M., see Archelos, J.J. (159) 127
Iseki, E., Li, F., Odawara, T., Hino, H., Suzuki, K., Kosaka, K., Miyoshi, T., see Fujihara, K. (159) 102
Akiyama, H., Ikeda, K. and Kato, M. Mochizuki, H., see Ugawa, Y. (159) 25
Ubiquitin-immunohistochemical investigation of atypical Pick’s Monaldo, B.C., see Troisi, E. (159) 115
disease without Pick bodies (159) 194 Moritake, K., see Ducrocq, X. (159) 145
Iwabuchi, K., see Sasaki, H. (159) 202 Murayama, S., see Sakurai, Y. (159) 156
Iwata, M., see Sakurai, Y. (159) 156 Murthy, J.M.K. and Subba Reddy, YV.
Izumo, S., see Hashimoto, K. (159) 67 Prognosis of epilepsy associated with single CT enhancing lesion:
Jin, Ya.-P., de Pedro-Cuesta, J., Séderstrém, M., Stawiarz, L. and Link, A long term follow up study (159) 151
H. Nagashima, K., see Ogata, A. (159) 135
Incidence of optic neuritis in Stockholm, Sweden 1990-1995: I. Neundo6rfer, B., see Hilz, M.J. (159) 219
Age, sex, birth and ethnic-group related patterns (159) 107 Newell, D.W., see Ducrocq, X. (159) 145
Jung, S., see Archelos, J.J. (159) 127 Nien, J.K., Schmidt, J., Cartier, L. and Alvarez, J.
Kanazawa, I., see Ugawa, Y. (159) 25 Cerebrospinal fluid of HTLV-1 associated myelopathy patients
Kao, K.-P., see Chen, C.-C. (159) 28 induces axonal sproutings and Schwann cell proliferation in the rat
Kato, K., see Toyoshima, I. (159) 38 sciatic nerve (159) 17
Kato, M., see Iseki, E. (159) 194 Nithi, K.A., see Mills, K.R. (159) 82
Kim, Y., Truettner, J., Zhao, W., Busto, R. and Ginsberg, M.D. Nonaka, I., see Ozawa, M. (159) 170
The influence of delayed postischemic hyperthermia following Odawara, T., see Iseki, E. (159) 194
transient focal ischemia: Alterations of gene expression (159) 1 Odawara, T., see Li, F. (159) 73
Kleinschmidt-DeMasters, B.K., see Gilden, D.H. (159) 140 Ogata, A., Nagashima, K., Yasui, K., Matsuura, T. and Tashiro, K.
Kleinschmidt-DeMasters, B.K., Mahalingam, R., Shimek, C., Marcoux, Sustained release dosage of thyrotropin-releasing hormone
H.L., Wellish, M., Tyler, K.L. and Gilden, D.H. improves experimental Japanese encephalitis virus-induced
Profound cerebrospinal fluid pleocytosis and Froin’s Syndrome parkinsonism in rats (159) 135
secondary to widespread necrotizing vasculitis in an HIV-positive Osame, M., see Hashimoto, K. (159) 67
patient with varicella zoster virus encephalomyelitis (159) 213 Ozawa, M., Nonaka, I. and Goto, Yu.-i.
Kobayashi, M., Hyodo, A., Kurokawa, T. and Ueno, S. Single muscle fiber analysis in patients with 3243 mutation in
The first component of polyphasic motor evoked potentials is mitochondrial DNA: Comparison with the phenotype and the
resistant to suppression by paired transcranial magnetic stimulation proportion of mutant genome (159) 170
in humans (159) 166 Pamphlett, R., Slater, M. and Thomas, S.
Kolawole, T., see Andeejani, A.M.I. (159) 11 Oxidative damage to nucleic acids in motor neurons containing
Kosaka, K., see Iseki, E. (159) 194 mercury (159) 121
Kosaka, K., see Li, F. (159) 73 Pedrol, E., see Masanés, F. (159) 226
Kotterba, S., Rasche, K., Widdig, W., Duscha, C., Blombach, S., Pelzl, B., see Finsterer, J. (159) 176
Schultze-Werninghaus, G. and Malin, J.-P. Pozzilli, C., see Filippi, M. (159) 94
Neuropsychological investigations and event-related potentials in Rasche, K., see Kotterba, S. (159) 45
obstructive sleep apnea syndrome before and during CPAP-therapy Reichelt, D., see Husstedt, LW. (159) 54
(159) 45 Reimers, C.D., Harder, T. and Saxe, H.
Kowa, H., see Toyoshima, I. (159) 38 Age-related muscle atrophy does not affect all muscles and can
Kurokawa, T., see Kobayashi, M. (159) 166 partly be compensated by physical activity: An ultrasound study
Lassmann, H., see Archelos, J.J. (159) 127 (159) 60
Li, F., see Iseki, E. (159) 194 Riedasch, M., see Husstedt, I.W. (159) 54
Li, F., Iseki, E., Odawara, T., Kosaka, K., Yagishita, S. and Amano, N. Rinner, W., see Archelos, J.J. (159) 127
Regional quantitative analysis of tau-positive neurons in Rocca, M.A., see Filippi, M. (159) 94
progressive supranuclear palsy: Comparison with Alzheimer’s Rocca, M.A., see Filippi, M. (159) 162
disease (159) 73 Rovaris, M., see Filippi, M. (159) 94
Liao, K.-K., see Chen, C.-C. (159) 28 Sakurai, Y., Murayama, S., Fukusako, Y., Bando, M., Iwata, M. and
Link, H., see Jin, Ya.-P. (159) 107 Inoue, K.
Machii, K., see Ugawa, Y. (159) 25 Progressive aphemia in a patient with Pick’s disease: a
Mahalingam, R., see Kleinschmidt-DeMasters, B.K. (159) 213 neuropsychological and anatomic study (159) 156
Malabarey, T.O., see Andeejani, A.M.I. (159) 11 Salih, M.A.M., see Andeejani, A.M.I. (159) 11
Malin, J.-P., see Kotterba, S. (159) 45 Sanpei, K., see Sasaki, H. (159) 202
Mamoli, B., see Finsterer, J. (159) 176 Sasaki, H., Wakisaka, A., Sanpei, K., Takano, H., Igarashi, S., Ikeuchi,
Author Index Volume 159 239
T., Iwabuchi, K., Fukazawa, T., Hamada, T., Yuasa, T., Tsuji, S. Kinesin and cytoplasmic dynein in spinal spheroids with motor
and Tashiro, K. neuron disease (159) 38
Phenotype variation correlates with CAG repeat length in SCA2 - Troisi, E., Attanasio, A., Matteis, M., Bragoni, M., Monaldo, B.C.,
A study of 28 Japanese patients (159) 202 Caltagirone, C. and Silvestrini, M.
Saxe, H., see Reimers, C.D. (159) 60 Cerebral hemodynamics in young hypertensive subjects and effects
Schmidt, J., see Nien, J.K. (159) 17 of atenolol treatment (159) 115
Schultze-Werninghaus, G., see Kotterba, S. (159) 45 Truettner, J., see Kim, Y. (159) 1
Sheetz, M.P., see Toyoshima, I. (159) 38 Tsuji, S., see Sasaki, H. (159) 202
Shimek, C., see Kleinschmidt-DeMasters, B.K. (159) 213 Tyler, K.L., see Kleinschmidt-DeMasters, B.K. (159) 213
Shiogai, T., see Ducrocq, X. (159) 145 Ueno, S., see Kobayashi, M. (159) 166
Shirouzu, I., see Ugawa, Y. (159) 25 Ugawa, Y., Shirouzu, I., Terao, Y., Hanajima, R., Machii, K.,
Shorny, S., see Finsterer, J. (159) 176 Mochizuki, H., Furubayashi, T. and Kanazawa, I.
Silvestrini, M., see Troisi, E. (159) 115 Physiological analyses of a patient with extreme widening of
Slater, M., see Pamphlett, R. (159) 121 Virchow—Robin spaces (159) 25
Smith, R.R., see Ducrocq, X. (159) 145 von Reutern, G.-M., see Ducrocq, X. (159) 145
Séderstrém, M., see Jin, Ya.-P. (159) 107 Wada, C., see Toyoshima, I. (159) 38
Song, D.D., see Gilden, D.H. (159) 140 Wakisaka, A., see Sasaki, H. (159) 202
Sprinz, A., see Husstedt, LW. (159) 54 Wellish, M., see Kleinschmidt-DeMasters, B.K. (159) 213
Stawiarz, L., see Jin, Ya.-P. (159) 107 Widdig, W., see Kotterba, S. (159) 45
Steiner, I., see Gilden, D.H. (159) 140 Wu, Z.-A., see Chen, C.-C. (159) 28
Subba Reddy, YV., see Murthy, J.M.K. (159) 151 Yagishita, S., see Li, F. (159) 73
Suda, H., see Hirohata, S. (159) 181 Yasui, K., see Ogata, A. (159) 135
Sugawara, M., see Toyoshima, I. (159) 38 Yee, A.S., see Gilden, D.H. (159) 140
Suzuki, K., see Iseki, E. (159) 194 Yuasa, T., see Sasaki, H. (159) 202
Takano, H., see Sasaki, H. (159) 202 Zhao, W., see Kim, Y. (159) 1
Tashiro, K., see Ogata, A. (159) 135 Zifko, U.A., Zipko, H.T. and Bolton, C.F.
Tashiro, K., see Sasaki, H. (159) 202 Clinical and electrophysiological findings in critical illness
Terao, Y., see Ugawa, Y. (159) 25 polyneuropathy (159) 186
Thomas, S., see Pamphlett, R. (159) 121 Zipko, H.T., see Zifko, U.A. (159) 186
Toniolo, D., see Fidzianska, A. (159) 88 Zwanikken, C., see De Keyser, J. (159) 51
Toyoshima, I., Sugawara, M., Kato, K., Wada, C., Hirota, K.,
Hasegawa, K., Kowa, H., Sheetz, M.P. and Masamune, O.
JOURNAL OF THE
NEUROLOGICAL
SCIENCES
Journal of the Neurological Sciences 159 (1998) 240-241
Subject Index Volume 159
4-Aminopyridine (159) 102 Electromagnetic vibrameter (159) 219
Activated protein C resistance (159) 209 Electrophysiology (159) 186
Adhesion molecules (159) 127 Emerin deficiency (159) 88
Adult T cell leukemia (ATL) (159) 67 Encephalomyelitis (159) 213
Albendazole (159) 151 Ethnic group (159) 107
Alzheimer’s disease (159) 73 Event-related potentials (ERP) (159) 45
Amyotrophic lateral sclerosis (159) 38, (159) 82, (159) 121 Evoked potentials (159) 54
Antibody (159) 140 Exercise (159) 60
Anticardiolipin antibodies (159) 209 Exercise stress test (159) 176
Antihypertensive therapy (159) 115 Factor V Leiden (159) 209
Aphemia (159) 156 Failure to wean (159) 186
Apraxia of speech (159) 156 Fast fluid attenuated inversion recovery (159) 94
Autoimmune disease (159) 127 Free radicals (159) 121
Autoradiography (159) 1 Froin’s Syndrome (159) 213
Behcet’s disease (159) 181 Frontotemporal dementia (159) 194
Bicycle ergometer (159) 176 Gadolinium—DTPA (159) 94, (159) 162
Bimodality (159) 107 Gene expression (159) 1
Birth-cohort (159) 107 Glia (159) 17
Brain death (159) 145 Glial fibrillary acidic protein (159) 1
Brain stem areflexia (159) 145 HAM (159) 17
Carotid angiography (159) 11 Heat shock protein (159) 1
Central motor conduction time (159) 82 Hereditary spinocerebellar ataxia (159) 202
Cerebral (159) 209 Heteroplasmy (159) 170
Cerebral angiography (159) 11 HIV (159) 213
Cerebral blood flow (159) 115 HIV infection (159) 54
Cerebral circulatory arrest (159) 145 HTLV-1 (159) 67
Cerebral death (159) 145 HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)
Cerebral infarction (159) 209 (159) 67
Cerebrospinal fluid (159) 181, (159) 213 Hypercoagulability (159) 209
Cerebrovascular reactivity (159) 115 Hypertension (159) 115
Children and adults (159) 219 Hyporeflexia (159) 202
Choreiform movements (159) 202 I wave (159) 166
CNS (159) 127 Immediate early genes (159) 1
Cognitive impairment (159) 45 Immunoelectron microscopy (159) 194
Coil orientation (159) 166 Immunohistochemistry (159) 73, (159) 194
Compound muscle action potential (159) 82 Immunosuppressant (159) 181
Correlation to immunological parameters (159) 54 In situ hybridization (159) 1
Cortico-basal degeneration (159) 73 In situ PCR (159) 67
Cortico-cortical inhibition (159) 166 Incidence (159) 107
Critical illness polyneuropathy (159) 186 Influenza (159) 51
CSF (159) 17, (159) 140 Influenza vaccination (159) 51
Cutaneous reflexes (159) 28 Inorganic mercury (159) 121
Cytoplasmic dynein (159) 38 Interleukin-6 (159) 181
D wave (159) 166 Japanese encephalitis virus (159) 135
Dementia (159) 181 Kinesin (159) 38
Demyelination (159) 17 Lacunar infarct (159) 28
Diaphragm (159) 186 Lower motor neurone (159) 82
Disc lesion (159) 151 Magnetic resonance imaging (159) 94, (159) 162
Distal motor latency (159) 82 Magnetic stimulation (159) 25
DNA (159) 121 Magnetization transfer ratio (159) 162
Doppler-sonography (159) 145 Messenger RNA (159) 1
EAE (159) 127 Middle cerebral artery occlusion (159) 1
EDMD (159) 88 Mitochondrial diabetes mellitus (159) 170
PII: $0022-510X(98)00236-6
Subject Index Volume 159
Mitochondrial DNA (159) 170 Pure motor syndrome (159) 28
Mitochondrial encephalopathy, myopathy, lactic acidosis, and stroke-like Pure sensory syndrome (159) 28
episodes (MELAS) (159) 170 Quantification (159) 73
Mitochondrial myopathies (159) 176 Quantitative sensory testing (159) 219
Mitochondrial toxicity (159) 226 Rat (159) 1
Molecular motor (159) 38 Remission (159) 151
Molecular studies (159) 226 Ring lesion (159) 151
Motor evoked potentials (159) 28 Ring lesion with scolex (159) 151
Motor neuron disease (159) 38 Schwann (159) 17
Motor neurons (159) 121 Sensorimotor syndrome (159) 28
Motor-evoked potential (MEP) (159) 102 Sensory tract lesion (159) 54
Moyamoya disease (159) 11 Single CT enhancing lesion (SCTEL) (159) 151
MRI (159) 25
Single muscle fiber analysis (159) 170
MRI in Moyamoya Disease (159) 11 Slow eye movement (159) 202
Multiple sclerosis (MS) (159) 51, (159) 94, (159) 102, (159) 107, (159)
Somatosensory evoked potentials (159) 28
162
Spheroid (159) 38
Muscle thickness (159) 60
Spinocerebellar ataxia-2 (159) 202
3243 mutation (159) 170
Sports (159) 60
Myelitis (159) 140
Subcutaneous fat (159) 60
Myopathy (159) 186
Systolic spikes (159) 145
Neurofibrillary tangles (159) 73
Tau (159) 73
Neuronal achromasia (159) 156
Thalamus (159) 28
Neuropsychological testing (159) 45
Therapy (159) 127
Non-fluent aphasia (159) 156
Thyrotropin-releasing hormone (TRH) (159) 135
Normative data (159) 219
Tibial/median nerve (159) 54
Nuclear architecture changes (159) 88
Toxic myopathy (159) 226
Obstructive sleep apnea syndrome (159) 45
Optic neuritis (159) 107 Transcranial Doppler ultrasonography (159) 115
Transcranial magnetic stimulation (159) 82
Oscillating flow (159) 145
Oxidative damage (159) 121 Treatment (159) 135, (159) 181
Paired magnetic stimulation (159) 166 Triple dose (159) 94
Parkinson’s disease (159) 135 Triplet repeat (159) 202
PCR (159) 140 Tropical spastic paraparesis (159) 17
Phrenic nerve (159) 186 Tuning fork (159) 219
Physical activity (159) 60 Ubiquitin (159) 194
Pick bodies (159) 156 Ultrasound (159) 60
Pick’s disease (159) 156, (159) 194 Upper motor neurone (159) 82
Pleocytosis (159) 213 Varicella zoster virus (159) 213
Polymerase chain reaction (159) 213 Vasculitis (159) 213
Polyphasic MEPs (159) 166 Venous lactate (159) 176
Post-encephalitic parkinsonism (159) 135 Vertebral angiography (159) 11
Pretangle neurons (159) 73 Vibration sense (159) 219
Primary progressive aphasia (159) 156 Vibratory thresholds (159) 219
Progressive supranuclear palsy (159) 73 Vigilance (159) 45
Proliferation (159) 17 Virchow—Robin space (159) 25
Prospective study (159) 54 VZV encephalitis (159) 140
Protease (159) 17 Zidovudine (159) 226
Protein C deficiency (159) 11